---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-036234"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2024-11-26T23:59:59+00:00"
generated_at: "2026-05-29T17:54:10.124089+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Controlling stockholder Robert Duggan cleared to buy up to 500k PLSE shares by Dec 10

## Summary
- Robert W. Duggan, controlling stockholder and Co-Chairman, authorized to purchase up to 500,000 shares of common stock through December 10, 2024.
- Purchases are at Mr. Duggan's sole discretion and depend on market conditions.
- Insider Trading Policy clearance obtained for the potential transactions.
- No obligation to purchase any shares; disclosure provided under Regulation FD.

## SEC filing metadata
- accession: 0001437749-24-036234
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2024-11-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774924036234/0001437749-24-036234-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774924036234/plse20241125_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-036234
- JSON: https://secwatch.observer/filing/0001437749-24-036234.json
- Plain text: https://secwatch.observer/filing/0001437749-24-036234.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.